Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Goodwill (2016 - 2025)

Historic Goodwill for Summit Therapeutics (SMMT) over the last 10 years, with Q3 2025 value amounting to $2.0 million.

  • Summit Therapeutics' Goodwill rose 40.18% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 40.18%. This contributed to the annual value of $1.9 million for FY2024, which is 153.2% down from last year.
  • Per Summit Therapeutics' latest filing, its Goodwill stood at $2.0 million for Q3 2025, which was up 40.18% from $2.0 million recorded in Q2 2025.
  • Over the past 5 years, Summit Therapeutics' Goodwill peaked at $2.1 million during Q2 2021, and registered a low of $1.7 million during Q3 2022.
  • In the last 5 years, Summit Therapeutics' Goodwill had a median value of $1.9 million in 2023 and averaged $1.9 million.
  • As far as peak fluctuations go, Summit Therapeutics' Goodwill surged by 61425.0% in 2021, and later plummeted by 1729.14% in 2022.
  • Quarter analysis of 5 years shows Summit Therapeutics' Goodwill stood at $2.0 million in 2021, then fell by 10.5% to $1.8 million in 2022, then rose by 5.28% to $1.9 million in 2023, then fell by 1.53% to $1.9 million in 2024, then grew by 7.24% to $2.0 million in 2025.
  • Its Goodwill stands at $2.0 million for Q3 2025, versus $2.0 million for Q2 2025 and $1.9 million for Q1 2025.